Skip to main content

Table 1 Demographic characteristics and CMR results in participants

From: Comparison of different cardiovascular magnetic resonance sequences for native myocardial T1 mapping at 3T

Variables Healthy Low added risk Moderate added risk Sig
(n = 9) (n = 18) (n = 13) (p value)
Age (years) 58.4 ± 11.1 59.2 ± 5.4 58.2 ± 5.7 0.93
Male gender (%) 33.3 44.4 53.8 0.64
Diabetes M. (%) 0 0 15.4 0.11
Dyslipidemia (%) 0 11.1 61.5 < .01
Obesity (%) 0 27.8 23.1 0.22
Current smoker (%) 0 11.1 0 0.57
Sedentary (%) 0 0 0
FH CVD (%) 0 72.2 38.5 < .01
Hypertension (%) 0 0 100 < .001
SBP (mmHg) 129.3 ± 21.4 134.3 ± 16.8 136.9 ± 20.2 0.66
DBP (mmHg) 74.8 ± 9.1 81.8 ± 9.2 79.3 ± 15.8 0.35
RF (0/1/2/3) 9/0/0/0 0/14/4/0 0/2/4/7 < .001
LVEDV (ml) 123.8 ± 26.4 121.9 ± 35.1 129.5 ± 29.6 0.80
LVESV (ml) 45.8 ± 13.4 39.3 ± 16.1 41.1 ± 12.8 0.55
EF (%) 63.1 ± 6.0 68.3 ± 6.2 68.4 ± 5.1 0.07
LVM (g) 99.9 ± 23.3 112.6 ± 31.3 127.8 ± 35.1 0.11
Native T1
ShMOLLI (ms) 1177.7 ± 28.6 1166.8 ± 24.3 1178.7 ± 51.7 0.70
MOLLI 5(3)3 (ms) 1207.9 ± 18.2 1197.0 ± 20.9 1206.8 ± 39.0 0.51
SASHA (ms) 1486.0 ± 24.1 1479.8 ± 29.6 1496.9 ± 48.9 0.44
  1. FH family history, CVD cardiovascular disease, SBP systolic blood pressure, DBP diastolic blood pressure, RF risk factors, LVEDV left-ventricular end-diastolic volume, LVESV left-ventricular end-systolic volume, EF ejection fraction, LVM left-ventricular mass, Sig significance